Centre de Documentation Campus Montignies
Horaires :
Lundi : 8h-18h30
Mardi : 8h-17h30
Mercredi 9h-16h30
Jeudi : 8h-18h30
Vendredi : 8h30-12h30 et 13h-14h30
Attention,
Votre centre de documentation sera fermé ce lundi 26 août.
Également, ce mercredi 28 août il sera fermé de 12 à 13h.
Enfin, ce jeudi 29 août il ouvrira à 14h45.
Lundi : 8h-18h30
Mardi : 8h-17h30
Mercredi 9h-16h30
Jeudi : 8h-18h30
Vendredi : 8h30-12h30 et 13h-14h30
Attention,
Votre centre de documentation sera fermé ce lundi 26 août.
Également, ce mercredi 28 août il sera fermé de 12 à 13h.
Enfin, ce jeudi 29 août il ouvrira à 14h45.
Bienvenue sur le catalogue du centre de documentation du campus de Montignies.
Détail de l'auteur
Auteur Carlo Cisari |
Documents disponibles écrits par cet auteur
![](./images/expand_all.gif)
![](./images/collapse_all.gif)
![Tris disponibles](./images/orderby_az.gif)
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature / Alessandro Picelli in Annals of physical and rehabilitation medicine, Vol. 62, n°4 (Juillet 2019)
![]()
[article]
Titre : Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature Type de document : texte imprimé Auteurs : Alessandro Picelli ; Andrea Santamato ; Elena Chemello ; Nicoletta Cinone ; Carlo Cisari ; Marialuisa Gandolfi ; Maurizio Ranieri ; Alessio Baricich Année de publication : 2019 Article en page(s) : p. 291-296 Note générale : doi.org/10.1016/j.rehab.2018.08.004 Langues : Anglais (eng) Mots-clés : Botulinum toxins Muscle spasticity Physical therapy modalities Rehabilitation Résumé : Background and objective
A wide range of adjunct therapies after botulinum toxin administration have been proposed. The aim of the present paper is to provide an overview of major writings dealing with adjuvant (non-pharmacological) treatments associated with botulinum toxin for managing spasticity in order to provide some up-to-date information about the usefulness of the most commonly used procedures.
Methods
The literature in PubMed was searched with the MeSH terms botulinum toxins, muscle spasticity, physical therapy modalities, and rehabilitation. The results were limited to studies focusing on adjuvant treatments associated with botulinum toxin for managing spasticity. We excluded papers on the use of non-drug treatments for spasticity not associated with botulinum toxin serotype A (BoNT-A) injection. Relevant literature known to the authors along with this complementary search represented the basis for this overview of the literature.
Results
Adhesive taping and casting effectively improved the botulinum toxin effect in patients with upper- and lower-limb spasticity. There is level 1 evidence that casting is better than taping for outcomes including spasticity, range of motion and gait. However, consensus about their most appropriate timing, duration, target and material is lacking. In terms of physical modalities combined with botulinum toxin injection, we found level 1 evidence that extracorporeal shock wave therapy is better than electrical stimulation for some post-injection outcomes including spasticity and pain. Furthermore, electrical stimulation of injected muscles might be useful to boost the toxin effect. However, the best stimulation protocol has not been defined. In addition, we found level 2b evidence that whole-body vibration therapy might reduce spasticity with cerebral palsy.
Conclusion
Future research in this field should focus on investigating the most appropriate post-injection treatment protocol for each goal to achieve.En ligne : https://www.sciencedirect.com/science/article/pii/S1877065718314453 Permalink : ./index.php?lvl=notice_display&id=84134
in Annals of physical and rehabilitation medicine > Vol. 62, n°4 (Juillet 2019) . - p. 291-296[article] Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature [texte imprimé] / Alessandro Picelli ; Andrea Santamato ; Elena Chemello ; Nicoletta Cinone ; Carlo Cisari ; Marialuisa Gandolfi ; Maurizio Ranieri ; Alessio Baricich . - 2019 . - p. 291-296.
doi.org/10.1016/j.rehab.2018.08.004
Langues : Anglais (eng)
in Annals of physical and rehabilitation medicine > Vol. 62, n°4 (Juillet 2019) . - p. 291-296
Mots-clés : Botulinum toxins Muscle spasticity Physical therapy modalities Rehabilitation Résumé : Background and objective
A wide range of adjunct therapies after botulinum toxin administration have been proposed. The aim of the present paper is to provide an overview of major writings dealing with adjuvant (non-pharmacological) treatments associated with botulinum toxin for managing spasticity in order to provide some up-to-date information about the usefulness of the most commonly used procedures.
Methods
The literature in PubMed was searched with the MeSH terms botulinum toxins, muscle spasticity, physical therapy modalities, and rehabilitation. The results were limited to studies focusing on adjuvant treatments associated with botulinum toxin for managing spasticity. We excluded papers on the use of non-drug treatments for spasticity not associated with botulinum toxin serotype A (BoNT-A) injection. Relevant literature known to the authors along with this complementary search represented the basis for this overview of the literature.
Results
Adhesive taping and casting effectively improved the botulinum toxin effect in patients with upper- and lower-limb spasticity. There is level 1 evidence that casting is better than taping for outcomes including spasticity, range of motion and gait. However, consensus about their most appropriate timing, duration, target and material is lacking. In terms of physical modalities combined with botulinum toxin injection, we found level 1 evidence that extracorporeal shock wave therapy is better than electrical stimulation for some post-injection outcomes including spasticity and pain. Furthermore, electrical stimulation of injected muscles might be useful to boost the toxin effect. However, the best stimulation protocol has not been defined. In addition, we found level 2b evidence that whole-body vibration therapy might reduce spasticity with cerebral palsy.
Conclusion
Future research in this field should focus on investigating the most appropriate post-injection treatment protocol for each goal to achieve.En ligne : https://www.sciencedirect.com/science/article/pii/S1877065718314453 Permalink : ./index.php?lvl=notice_display&id=84134 Exemplaires (1)
Cote Support Localisation Section Disponibilité Revue Revue Centre de Documentation HELHa Campus Montignies Armoires à volets Document exclu du prêt - à consulter sur place
Exclu du prêtBlurred lines between axillary web syndrome and Mondor's disease after breast cancer surgery : A case report / Allessandro de Sire in Annals of physical and rehabilitation medicine, Vol. 63, n°4 (Juillet 2020)
[article]
Titre : Blurred lines between axillary web syndrome and Mondor's disease after breast cancer surgery : A case report Type de document : texte imprimé Auteurs : Allessandro de Sire ; Marco Invernizzi ; Lorenzo Lippi ; Carlo Cisari ; Levent Özçakar ; Franco Franchignoni Année de publication : 2020 Article en page(s) : p. 365-367 Note générale : doi.org/10.1016/j.rehab.2019.04.007 Langues : Anglais (eng) Mots-clés : Axillary web syndrome Mondor's disease Breast cancer Ultrasonography Rehabilitation Permalink : ./index.php?lvl=notice_display&id=90884
in Annals of physical and rehabilitation medicine > Vol. 63, n°4 (Juillet 2020) . - p. 365-367[article] Blurred lines between axillary web syndrome and Mondor's disease after breast cancer surgery : A case report [texte imprimé] / Allessandro de Sire ; Marco Invernizzi ; Lorenzo Lippi ; Carlo Cisari ; Levent Özçakar ; Franco Franchignoni . - 2020 . - p. 365-367.
doi.org/10.1016/j.rehab.2019.04.007
Langues : Anglais (eng)
in Annals of physical and rehabilitation medicine > Vol. 63, n°4 (Juillet 2020) . - p. 365-367
Mots-clés : Axillary web syndrome Mondor's disease Breast cancer Ultrasonography Rehabilitation Permalink : ./index.php?lvl=notice_display&id=90884 Exemplaires (1)
Cote Support Localisation Section Disponibilité Revue Revue Centre de Documentation HELHa Campus Montignies Armoires à volets Document exclu du prêt - à consulter sur place
Exclu du prêtElectrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study / Alessio Baricich in Annals of physical and rehabilitation medicine, Vol. 62, n°4 (Juillet 2019)
![]()
[article]
Titre : Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study Type de document : texte imprimé Auteurs : Alessio Baricich ; Alessandro Picelli ; Stefano Carda ; Nicola Smania ; Carlo Cisari ; Andrea Santamato ; Allessandro de Sire ; Marco Invernizzi Année de publication : 2019 Article en page(s) : p. 214-219 Note générale : https://doi.org/10.1016/j.rehab.2019.06.002 Langues : Anglais (eng) Mots-clés : Stroke Spasticity Botulinum toxin type A Electrical stimulation Rehabilitation Résumé : Background
Botulinum toxin type A (BoNT-A) injection is an effective treatment for lower-limb spasticity and should be offered as first-line treatment for focal manifestations. Although its possible role has been hypothesized, the efficacy of electrical stimulation (ES) of antagonists of the injected muscles for improving clinical outcome after BoNT-A injection remains to be established.
Objectives
This randomized single-blind pilot study aimed to investigate the efficacy of ES of antagonist muscles as adjunct treatment after BoNT-A injection to plantar flexor muscles in hemiplegic patients with spastic equinus foot.
Methods
After BoNT-A injection at triceps surae, patients were randomly allocated to 2 groups: group 1, single ES session on injected muscles plus 5 sessions of ES on antagonist muscles, and group 2, single ES session on injected muscles alone. Both groups underwent daily physical therapy for 60 min for 2 weeks (5 days/week). Assessments were performed before treatment (T0) and at 10 days (T1), 20 days (T2), and 90 days (T3) after treatment. Our primary outcome was gait velocity at a comfortable speed at T2 (10-m walk test [10MWT]). The following were secondary outcomes: triceps surae spasticity (Modified Ashworth Scale), ankle passive range of motion (pROM), strength of tibialis anterior muscle, and 2-min walk test (2MWT).
Results
The 30 patients enrolled were randomly allocated to the 2 groups: 15 in group 1 and 15 in group 2. At T1, T2 and T3, both groups showed a significant reduction in muscle tone and an increase in ankle pROM (P < 0.05). At T2 and T3, both groups showed a significant increase in 10MWT and 2MWT. The groups did not significantly differ in tibialis anterior strength or primary or secondary outcome measures.
Conclusions
ES of antagonist muscles does not improve clinical outcomes in the post-stroke spastic equinus foot after BoNT-A injection.En ligne : https://www.sciencedirect.com/science/article/pii/S1877065719300752 Permalink : ./index.php?lvl=notice_display&id=84125
in Annals of physical and rehabilitation medicine > Vol. 62, n°4 (Juillet 2019) . - p. 214-219[article] Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study [texte imprimé] / Alessio Baricich ; Alessandro Picelli ; Stefano Carda ; Nicola Smania ; Carlo Cisari ; Andrea Santamato ; Allessandro de Sire ; Marco Invernizzi . - 2019 . - p. 214-219.
https://doi.org/10.1016/j.rehab.2019.06.002
Langues : Anglais (eng)
in Annals of physical and rehabilitation medicine > Vol. 62, n°4 (Juillet 2019) . - p. 214-219
Mots-clés : Stroke Spasticity Botulinum toxin type A Electrical stimulation Rehabilitation Résumé : Background
Botulinum toxin type A (BoNT-A) injection is an effective treatment for lower-limb spasticity and should be offered as first-line treatment for focal manifestations. Although its possible role has been hypothesized, the efficacy of electrical stimulation (ES) of antagonists of the injected muscles for improving clinical outcome after BoNT-A injection remains to be established.
Objectives
This randomized single-blind pilot study aimed to investigate the efficacy of ES of antagonist muscles as adjunct treatment after BoNT-A injection to plantar flexor muscles in hemiplegic patients with spastic equinus foot.
Methods
After BoNT-A injection at triceps surae, patients were randomly allocated to 2 groups: group 1, single ES session on injected muscles plus 5 sessions of ES on antagonist muscles, and group 2, single ES session on injected muscles alone. Both groups underwent daily physical therapy for 60 min for 2 weeks (5 days/week). Assessments were performed before treatment (T0) and at 10 days (T1), 20 days (T2), and 90 days (T3) after treatment. Our primary outcome was gait velocity at a comfortable speed at T2 (10-m walk test [10MWT]). The following were secondary outcomes: triceps surae spasticity (Modified Ashworth Scale), ankle passive range of motion (pROM), strength of tibialis anterior muscle, and 2-min walk test (2MWT).
Results
The 30 patients enrolled were randomly allocated to the 2 groups: 15 in group 1 and 15 in group 2. At T1, T2 and T3, both groups showed a significant reduction in muscle tone and an increase in ankle pROM (P < 0.05). At T2 and T3, both groups showed a significant increase in 10MWT and 2MWT. The groups did not significantly differ in tibialis anterior strength or primary or secondary outcome measures.
Conclusions
ES of antagonist muscles does not improve clinical outcomes in the post-stroke spastic equinus foot after BoNT-A injection.En ligne : https://www.sciencedirect.com/science/article/pii/S1877065719300752 Permalink : ./index.php?lvl=notice_display&id=84125 Exemplaires (1)
Cote Support Localisation Section Disponibilité Revue Revue Centre de Documentation HELHa Campus Montignies Armoires à volets Document exclu du prêt - à consulter sur place
Exclu du prêt